Viewing Study NCT04012801



Ignite Creation Date: 2024-05-06 @ 1:24 PM
Last Modification Date: 2024-10-26 @ 1:13 PM
Study NCT ID: NCT04012801
Status: UNKNOWN
Last Update Posted: 2020-03-04
First Post: 2019-06-22

Brief Title: Evaluation of C13 Breath Test for Upper Gastrointestinal Bleeding in Patients Who Need Double Antiplatelet After PCI
Sponsor: Chongqing Medical University
Organization: Chongqing Medical University

Study Overview

Official Title: Evaluation of C13 Breath Test for Upper Gastrointestinal Bleeding in Patients of Acute Myocardial Infarction Who Need Double Antiplatelet After PCI
Status: UNKNOWN
Status Verified Date: 2020-03
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hp infection is closely related to upper gastrointestinal bleeding in patients who need dual-antiplatelet after PCI Taking anti-Hp treatment has the effect of reducing bleeding risk Thus we propose a scientific hypothesis the C13 breath test may be used to assess the risk of upper gastrointestinal bleeding in patients who need dual- antiplatelet after PCI
Detailed Description: Our study is to retrospectively analyze the clinical data of 1606 patients of acute myocardial infarction who need dual- antiplatelet after PCIThe diagnostic criteria for upper gastrointestinal bleeding is 1symptoms digestive discomfort such as abdominal pain nausea belching acid reflux etc2mainly based on endoscopy examination endoscopic examination showed that the stomach or duodenum showed spotted linear or diffuse bleeding3the fecal examinationmelena tar-like stool hematemesis fecal occult blood etcThe study was divided into two groups according to whether the C13 breath test was performed and the C13 breath test component was the positive anti-HP treatment group and the non-anti-HP treatment groupAnd then compare the upper gastrointestinal bleeding rates of the above groups

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None